Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease
Stargardt Disease Stargardt Macular Degeneration Stargardt Macular Dystrophy Autosomal Recessive Stargardt Disease 1 (ABCA4-related) Macular Degeneration Vitamin A Retinol acetate ALK-001
Lead Scientist at UC Health
- Michael Gorin, MD, PhD (ucla)
Professor, Ophthalmology. Authored (or co-authored) 59 research publications.
- accepting new patients
- Start Date
- Completion Date
- Alkeus Pharmaceuticals, Inc.
- Please leave your name if you would like to be contacted to discuss this trial
- Phase 2
- Study Type
- Last Updated